Tesla Inc. is delaying its planned robotaxi unveiling to October to allow teams working on the project more time to build additional vehicle prototypes, according to people familiar with the decision.
Chief Executive Officer Elon Musk set the initial Aug. 8 date for the event months ago, and optimism about the spectacle has contributed to an 11-day streak of gains that?s added more than $257 billion to Tesla?s market capitalization. The stock fell more than 8% in intraday trading Thursday after Bloomberg News first reported the delay. The postponement has been communicated internally, said the people, who asked not to be identified because the information hadn?t been publicly announced.
The idea of creating an autonomous taxi service has been kicking around Tesla for at least eight years, dating back to when Musk authored a second iteration of his ?master plan? for the company. The CEO has prioritized the project in recent months over work on an electric vehicle cheaper than Tesla?s most affordable car, the Model 3 sedan.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Tesla reportedly delaying its robotaxi reveal until OctoberTesla delayed its robotaxi reveal event until October to give its engineers more time to build and test prototypes, Bloomberg reports.
Read more »
Tesla Gets Countertrend Rally Going But Risks Keep Piling UpStocks Analysis by Investing.com (Alessandro Bergonzi) covering: Alphabet Inc Class A, Tesla Inc, Alphabet Inc Class C. Read Investing.com (Alessandro Bergonzi)'s latest article on Investing.com
Read more »
Tesla: Should You Buy the Stock Before Firm’s Q2 Deliveries Report?Stocks Analysis by The Tokenist (Timothy Fries) covering: Renault SA, Alphabet Inc Class A, Baidu Inc, Tesla Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »
Fisker tried to out Tesla Tesla, and now it’s bankruptFisker finally declared bankruptcy, proving that trying to follow Tesla’s playbook isn’t exactly foolproof, especially when your name isn’t Elon Musk.
Read more »
These 3 Clinical-Stage Biotech Stocks Can Offer Exponential GainsStocks Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket Pharmaceuticals Inc, Arvinas Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »
3 Mega-Cap Tech Stocks You Must Own in JulyStocks Analysis by Investing.com (Jesse Cohen) covering: Alphabet Inc Class A, Apple Inc, Amazon.com Inc, Alphabet Inc Class C. Read Investing.com (Jesse Cohen)'s latest article on Investing.com
Read more »